Laboratory Reference Grade Compounds

Teriparatide / rhPTH (1-34) (10mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱4,500.00
Out of stock
InclusionVial Only
Net Content10MG
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose20 mcg – 40 mcg daily pulsatile research exposureSyringe: 10.0 IU = 500 mcg at 5.0 mg/mL
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
Teriparatide / rhPTH (1-34) (10mg Research Vial)10MG · Vial Only
₱4,500.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

Teriparatide is the synthetic 34-amino-acid N-terminal bioactive fragment of recombinant human parathyroid hormone [rhPTH(1-34)]. When administered in intermittent pulsatile regimens, Teriparatide selectively stimulates osteoblast survival and bone matrix deposition over osteoclast resorption, accelerating bone mineral density accretion, microarchitectural repair, and periosteal callus formation in preclinical fracture models.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryTissue Repair & Healing
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number52232-67-4
PubChem CID444212↗
Molecular Weight4117.77 g/mol
Purity Specification≥99.0% (RP-HPLC)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF (C181H291N55O51S2)